Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Syros Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

  • $81.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$6.66 - $14.66 $137,828 - $303,388
-20,695 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$8.69 - $14.47 $590 - $983
-68 Reduced 0.33%
20,695 $183,000
Q2 2020

Aug 06, 2020
BUY
$5.21 - $11.03 $108,175 - $229,015
20,763 New
20,763 $221,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email